Almanax Secures $1M to Advance AI-Driven Web3 Security Solutions

New York-based AI Web3 security firm Almanax has raised $1 million in funding from investors including Blockchain Builders Fund, Exor Ventures, Vento Ventures, Italian Angels for Growth, Eden Ventures, Moonbase, and a group of angel investors. The funding will support the expansion of its team and the development of its Web3 Security Atlas, an open-source initiative created in partnership with TRM Labs, AnChain.AI, Hypernative, and backed by the Stellar Development Foundation.

Founded in 2024 by Francesco Piccoli, Giorgio Demarchi, and Maxwell Watson, Almanax focuses on addressing security challenges within the Web3 ecosystem. Its flagship platform, ALMX-1, enables engineers to detect vulnerabilities in smart contracts under real-world conditions. The company is also working on ALMX-2, a next-generation model designed to enhance support for multiple programming languages.

Almanax’s solutions aim to strengthen the security infrastructure of decentralized systems, catering to the increasing demand for robust protections in the rapidly evolving Web3 space. The team’s efforts are expected to further empower developers and organizations to mitigate risks and enhance trust in blockchain-based technologies.

Featured image: Credit: Almanax

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

Amazon Launches Agentic AI Assistant ‘Alexa for Shopping’

Insider Brief Amazon is rolling out a new AI-powered shopping assistant called Alexa for Shopping that combines conversational AI, personalized recommendations and automation tools across

Autonomous Defense Tech Company Anduril Announces $5B Series H Funding Round

Insider Brief Defense technology company Anduril Industries has raised $5 billion in a Series H funding round to expand manufacturing capacity and autonomous defense systems

Global AI Life Sciences
Study Finds AI Competitiveness in Life Sciences Depends on Data, Regulation And Capital

Insider Brief Artificial intelligence is moving from laboratory experiments into the core infrastructure of drug discovery, healthcare delivery and preventive medicine, according to a new

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape